Home' Australian Pharmacist : Australian Pharmacist July 2015 Contents Australian Pharmacist July 2015 I © Pharmaceutical Society of Australia Ltd.
CONTINUING PROFESSIONAL DEVELOPMENT
KNOWLEDGE IN PRACTICE
The challenge of applying what
you learn to pharmacy practice!
Knowledge in practice is designed to
be difficult and aims to make you apply
information from articles in this month’s
Australian Pharmacist and other suggested
reading to the questions below, just as you
would for a client/patient. This section is not
meant to be easy. There are no simple clear-
cut answers to the questions. The standard
references listed below may be of use when
answering the questions.
1. Sansom LN, ed. Australian pharmaceutical
formulary and handbook, 23rd edn. Canberra:
Pharmaceutical Society of Australia; 2015.
2. Rossi S, ed. Australian medicines handbook.
Adelaide: Australian Medicines Handbook; 2015.
3. NPS MedicineWise. At: www.nps.org.au
4. Merck Manual of Diagnosis and Therapy.At: www.
5. Product information – available from various
sources, e.g. MIMS, APP Guide or online on
6. Royal College of Pathologists of Australasia. RCPA
Manual. At: www.rcpamanual.edu.au
7. Therapeutic Guidelines Series. eTG complete.
Melbourne: Therapeutic Guidelines Limited.
Knowledge in practice
TO ANSWER KNOWLEDGE IN
Answers for Knowledge in practice can only be
submitted online through the PSA members-only
area of the PSA website at: www.psa.org.au
PSA members will receive instant feedback on
the correct answers with an explanation of why
the answer is correct. If you do not have member
access details for the PSA website, you can request
them via a link from the login page.
Question 1. Medication review
Additional reference: Kim S, Liu S, Tse V. Management of urinary incontinence in adults. Aust Prescr
2014;37:10–3 . At: www.tinyurl.com/apv34071
Mrs Montgomery (78 years old) is referred for a Home Medicines Review (HMR), as her
son is concerned that his mother is having difficulty remembering whether or not she
has taken her medicines each day. She has a history of:
• chronic obstructive pulmonary
disease (ex-heavy smoker)
• ischaemic heart disease
• severe reflux oesophagitis
• stress urinary incontinence.
Her current medications are:
• atorvastatin (Lipitor) 80 mg at night
• calcium carbonate (Caltrate) 1,500 mg
in the morning
• colecalciferol (Ostevit-D) 25 mcg in the
• glyceryl trinitrate (Nitro-lingual)
400 mcg 1–2 sprays when required
• imipramine (Tofranil) 50 mg at night
• metoprolol (Betaloc) 25 mg twice daily
• perindopril/indapamide (Coversyl Plus)
5/1.25 mg in the morning
• rabeprazole 20 mg in the morning
• salbutamol 100 mcg 1–2 inhalations
During the HMR interview, Mrs Montgomery mentions that she has had several recent
falls. She is worried that she will fall again and seriously injure herself. She is also
concerned that her incontinence is poorly controlled despite pelvic floor training
exercises given to her by a continence nurse, and she regularly experiences ‘accidents’
Which ONE of the following statements regarding Mrs Montgomery’s management is
the MOST appropriate at this time?
a) She should commence strontium ranelate.
b) She should commence mirabegron.
c) Imipramine should be changed to duloxetine.
d) She should commence once-weekly alendronate.
Through successful completion of this activity, the
learner will demonstrate their ability to:
• Use readily available information sources to
access and select relevant and up-to-date
clinical and practice-based information
• Promote and contribute to the optimal use of
• Address primary healthcare needs of patients.
Competency standards (2010) addressed: 4.2,
6.1, 7.1, 7.2 .
Accreditation number: CAP150606F
31 AUGUST, 7–8PM AEST
UPCOMING NATIONAL WEBINARS
14 July – Pharmacists in General Practice
31 August – New respiratory medicines
1 September – Mental health
6 October – Cardiovascular disease
Links Archive Australian Pharmacist June 2015 Australian Pharmacist August 2015 Navigation Previous Page Next Page